It is our great pleasure to announce that LKF – Laboratorium für Klinische Forschung GmbH - has reorganized the board of directors with the beginning of the new year: Dr. Gerrit Schoenicke, MD and Dr. Volker El-Samalouti have taken over the role as managing directors and, together with Bärbel Wilke, they will be responsible for the ongoing development of the company. Former managing director Uwe Troge will remain responsible as an authorized signatory.

DCONex in Essen is a specialist congress with an accompanying exhibition on the subject of pollutant management. On January 19th and 20th 2022, interested parties and technical personnel can inform themselves and exchange technical information on a variety of topics.